New Pharmaceutical Brands Require Larger Marketing Investments due to Unstable Market

Nov. 22, 2011 - PRLog -- According to the report “Pre-Launch Planning: Priming Your Pharmaceutical Brand for Profit and Success 2011” available at http://www.pharmaceutical-market-research.com/publications/sales_marketing/pre_launch_planning.html in today's environment, Pharmaceutical companies find themselves in a tight spot. Until recently, if drugs made over $500 Million in annual revenue within three to five years of launch, they were seen as very successful. They were a support to a broad company portfolio and a factor for greater company profit.

However, things have changed. The standards for a thriving drug have become much higher and much more unstable. Everyone is searching for the new product that posts incredible sales from the moment it's on the market, and if they don't find it, business could suffer.

The reasons behind this are easy to understand. With so many revenue-producing drugs going off patent shortly (Lipitor, Cozaar, Fosamax, Singulair, etc.), companies are facing sales that are increasingly slow as well as large holes in their balance sheets. In addition, with the stakes high and available funds low, pipelines are drying up. Add to this the closer scrutiny of safety issues, the rise of Generics, slower physician acceptance and adoption of new therapies, and the Pharma Industry is in trouble.

This report analyses the environment for pharmaceuticals today in efforts to understand why the launch is increasingly important. This research describes the phases of pre-launch planning; looking at key organisational strategies, marketing tactics, regulatory considerations, and even global issues.

The report “Pre-Launch Planning: Priming Your Pharmaceutical Brand for Profit and Success
2011” is available from Piribo at:
http://www.pharmaceutical-market-research.com/publication...

Piribo product ID: ELA00003

About Piribo

Piribo http://www.pharmaceutical-market-research.com/publications/sales_marketing/pre_launch_planning.html is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.